Medical Implants Company Investment Opportunity in Haifa, Israel

- The company develops human bone tissue for implantation in patients with bone fractures, instability in the spine, or bone gaps following trauma or previous surgery.
- We are currently in the development stage, hence there is no revenue generation and the figures are not given.
- The product is tailored for a specific patient because it uses bone cells and blood components.
- Therefore, this product is individualized for a patient and should not be rejected.
- We have already successfully passed the FDA pre-IND process with a positive feedback.
- Patents have already been issued in the EU, USA, Switzerland, and Israel.
- The method, its efficiency, and safety were described in two scientific papers published in.
Highly ranked peer-reviewed journals.
- Have conducted preliminary testing to demonstrate the feasibility of the product.
- Led by a highly qualified CEO who is an expert in bone cell culturing and has multiple qualifications like MD, MOrthop, MBA, and FRCS (England).
- It is expected to require an additional 2 years after securing funding to obtain necessary approvals from the FDA and European authorities.
- The bone grafting market is estimated to be above USD 10 billion.
- Since currently there is no clinically used method for personalized bone grafting material supplementation, the appearance of such a product will even increase the market evaluation.